Clinical trial
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
NCT00379470 · NovoCure Ltd., Industry · Completed
Key facts
| NCT number | NCT00379470 |
|---|---|
| Title | Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) |
| Official title | A Prospective, Multi-center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients With Progressive or Recurrent GBM |
| Lead sponsor | NovoCure Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Recurrent Glioblastoma Multiforme |
| Intervention type | Device |
| Interventions | NovoTTF-100A |
| Enrollment | 236 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Sep 21, 2006 |
| Last update posted | May 1, 2012 |
| Countries | Austria, Czechia, France, Germany, Israel, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: